Fact CheckerSign in

NCT07780097Enrolling by invitation

TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization

A Pilot Randomized Controlled Trial to Improve Outpatient Initiation of Medication for Opioid Use Disorder (MOUD) Following Hospitalization: The TRTME (Tailored Overdose Risk Feedback, Testimonials for MOUD Treatment, and Education on MOUD and Opioid Overdose) Trial

Source: ClinicalTrials.gov · Last updated 28 Sept 2026

Brief summary (registry, in English)

The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
30 (estimated)
First submitted
11 Aug 2026
Start date
19 Aug 2026
Primary completion date
28 Feb 2027
Lead sponsor
T. John Winhusen, PhD
NCT number
NCT07780097

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 19 Aug 2026 to the primary completion date, 28 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Have a current planned discharge to a nursing facility
  • be currently in jail, prison, or any inpatient overnight facility as required by court of law or have pending legal action with high probability of incarceration or court-mandated inpatient treatment
  • Unable to demonstrate adequate understanding of study procedures during the consent process

Who the study is looking for

  • 18 years of age or older;
  • A good candidate for methadone or buprenorphine treatment according to a member of the UCMC Addiction Consult Team

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Cincinnati Addiction Sciences Division
Coordinator of this site? Confirm its status
CincinnatiUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.